These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 35647937)

  • 1. Possible Role of Matrix Metalloproteinases and TGF-β in COVID-19 Severity and Sequelae.
    Ramírez-Martínez G; Jiménez-Álvarez LA; Cruz-Lagunas A; Ignacio-Cortés S; Gómez-García IA; Rodríguez-Reyna TS; Choreño-Parra JA; Zúñiga J
    J Interferon Cytokine Res; 2022 Aug; 42(8):352-368. PubMed ID: 35647937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 and pathological matrix remodeling mediators.
    Guizani I; Fourti N; Zidi W; Feki M; Allal-Elasmi M
    Inflamm Res; 2021 Aug; 70(8):847-858. PubMed ID: 34286362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing of histone deacetylase inhibitors: A promising strategy to combat pulmonary fibrosis promoted by TGF-β signalling in COVID-19 survivors.
    P KM; Sivashanmugam K; Kandasamy M; Subbiah R; Ravikumar V
    Life Sci; 2021 Feb; 266():118883. PubMed ID: 33316266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the extracellular matrix in COVID-19.
    Huang JJ; Wang CW; Liu Y; Zhang YY; Yang NB; Yu YC; Jiang Q; Song QF; Qian GQ
    World J Clin Cases; 2023 Jan; 11(1):73-83. PubMed ID: 36687194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the interaction between tumor growth factor-β and interferon type I pathways in patients with COVID-19: focusing on ages 1 to 90 years.
    Abbasifard M; Fakhrabadi AH; Bahremand F; Khorramdelazad H
    BMC Infect Dis; 2023 Apr; 23(1):248. PubMed ID: 37072722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis.
    Boumaza A; Gay L; Mezouar S; Bestion E; Diallo AB; Michel M; Desnues B; Raoult D; La Scola B; Halfon P; Vitte J; Olive D; Mege JL
    J Infect Dis; 2021 Aug; 224(3):395-406. PubMed ID: 33493287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
    Azar MM; Shin JJ; Kang I; Landry M
    Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of COVID-19-induced pulmonary fibrosis and epithelial-mesenchymal transition.
    Pi P; Zeng Z; Zeng L; Han B; Bai X; Xu S
    Front Pharmacol; 2023; 14():1218059. PubMed ID: 37601070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-COVID-19 Pulmonary Fibrosis.
    Mohammadi A; Balan I; Yadav S; Matos WF; Kharawala A; Gaddam M; Sarabia N; Koneru SC; Suddapalli SK; Marzban S
    Cureus; 2022 Mar; 14(3):e22770. PubMed ID: 35371880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulated Immune Responses in COVID-19 Patients Correlating With Disease Severity and Invasive Oxygen Requirements.
    García-González P; Tempio F; Fuentes C; Merino C; Vargas L; Simon V; Ramirez-Pereira M; Rojas V; Tobar E; Landskron G; Araya JP; Navarrete M; Bastias C; Tordecilla R; Varas MA; Maturana P; Marcoleta AE; Allende ML; Naves R; Hermoso MA; Salazar-Onfray F; Lopez M; Bono MR; Osorio F
    Front Immunol; 2021; 12():769059. PubMed ID: 34745145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TB and COVID-19: An Exploration of the Characteristics and Resulting Complications of Co-infection.
    Luke E; Swafford K; Shirazi G; Venketaraman V
    Front Biosci (Schol Ed); 2022 Mar; 14(1):6. PubMed ID: 35320917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microvascular significance of TGF-β axis activation in COVID-19.
    Arguinchona LM; Zagona-Prizio C; Joyce ME; Chan ED; Maloney JP
    Front Cardiovasc Med; 2022; 9():1054690. PubMed ID: 36684608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2-Specific Antibody and T Cell Response Kinetics According to Symptom Severity.
    Kim JY; Kwon JS; Bae S; Cha HH; Lim JS; Kim MC; Chung JW; Park SY; Lee MJ; Kim BN; Jung J; Kim MJ; Shin EC; Kim SH
    Am J Trop Med Hyg; 2021 Jun; 105(2):395-400. PubMed ID: 34143752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology.
    Steiner S; Schwarz T; Corman VM; Sotzny F; Bauer S; Drosten C; Volk HD; Scheibenbogen C; Hanitsch LG
    Front Immunol; 2021; 12():687449. PubMed ID: 34322120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac Fibrosis Is a Risk Factor for Severe COVID-19.
    Mustroph J; Hupf J; Baier MJ; Evert K; Brochhausen C; Broeker K; Meindl C; Seither B; Jungbauer C; Evert M; Maier LS; Wagner S
    Front Immunol; 2021; 12():740260. PubMed ID: 34745111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection.
    Gerhards C; Thiaucourt M; Kittel M; Becker C; Ast V; Hetjens M; Neumaier M; Haselmann V
    Int J Infect Dis; 2021 Jun; 107():221-227. PubMed ID: 33932604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
    Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
    Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting MMP-Regulation of Inflammation to Increase Metabolic Tolerance to COVID-19 Pathologies: A Hypothesis.
    Hardy E; Fernandez-Patron C
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33800947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.